We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

35 hedge funds and large institutions have $31.2M invested in Orchard Therapeutics plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $16.3M → $31.2M (+$14.9M)

26% less funds holding

Funds holding: 47 → 35 (-12)

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

60% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 20

Holders
35
Holders Change
-12
Holders Change %
-25.53%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
13
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$6.34M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$5.9M
3
Citigroup
Citigroup
New York
+$912K
4
KI
Kapitalo Investimentos
Brazil
+$779K
5
PIM
Platinum Investment Management
Australia
+$648K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.46M
2
TCM
Tang Capital Management
California
-$816K
3
AG
Artal Group
Luxembourg
-$669K
4
Citadel Advisors
Citadel Advisors
Florida
-$577K
5
Renaissance Technologies
Renaissance Technologies
New York
-$506K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$2.04K -$7.09K -1,304 -77%
Barclays
27
Barclays
United Kingdom
$1.07K – – –
Northwestern Mutual Wealth Management
28
Northwestern Mutual Wealth Management
Wisconsin
$806 +$816 +150 New
CWP
29
Concord Wealth Partners
Virginia
$537 – – –
BHWM
30
Beaird Harris Wealth Management
Texas
$65 – – –
MAWCM
31
Mine & Arao Wealth Creation & Management
California
$54 – – –
AAG
32
Armstrong Advisory Group
Massachusetts
$27 – – –
Group One Trading
33
Group One Trading
Illinois
$5 +$5 +1 New
AG
34
Artal Group
Luxembourg
– -$669K -180,386 Closed
Millennium Management
35
Millennium Management
New York
– -$119K -31,952 Closed
Jane Street
36
Jane Street
New York
– -$28.1K -7,564 Closed
AFG
37
Allegheny Financial Group
Pennsylvania
– -$10.7K -2,875 Closed
Geode Capital Management
38
Geode Capital Management
Massachusetts
– -$9K -2,608 Closed
TSS
39
Two Sigma Securities
New York
– -$9.41K -2,536 Closed
BCV
40
Banque Cantonale Vaudoise
Switzerland
– -$8K -2,400 Closed
Two Sigma Investments
41
Two Sigma Investments
New York
– -$8.13K -2,191 Closed
CS
42
Cannell & Spears
New York
– -$7.84K -2,115 Closed
Two Sigma Advisers
43
Two Sigma Advisers
New York
– -$7.83K -2,110 Closed
SG
44
StoneX Group
New York
– -$5.57K -1,500 Closed
HIC
45
Holderness Investments Company
North Carolina
– -$5.46K -1,473 Closed
IIA
46
IPG Investment Advisors
California
– -$5.23K -1,410 Closed
VF
47
Virtu Financial
New York
– -$4K -1,202 Closed
HighTower Advisors
48
HighTower Advisors
Illinois
– -$4K -1,200 Closed
OC
49
Oppenheimer & Co
New York
– -$4.27K -1,150 Closed
LG
50
Lane Generational
Massachusetts
– -$4.02K -1,083 Closed
1
2
3

ORTX Hedge Fund Activity: Q1 2023 in Review

35 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2023, worth a combined $31.2M — up 91% from $16.3M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ORTX and 8 opened new positions — a net loss of 12 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $6.34M. The largest seller was Fidelity Investments, cutting an estimated $4.46M.

  • 35 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2023, down from 47 in Q4 2022.
  • Funds reported $31.2M of Orchard Therapeutics plc American Depositary Shares stock for Q1 2023, up 91% quarter-over-quarter.
  • 8 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2023 and 20 closed out, a net change of -12 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q1 2023 was Deep Track Capital, an estimated $6.34M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2023 was Fidelity Investments, an estimated $4.46M sold.

Based on aggregated 13F filings for Q1 2023.